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 Headaches are a common complaint in HIV positive patients 
attending emergency services. A thorough understanding of 
the differential diagnoses, initial investigations and empirical 
management of this presentation is essential for the assessing 
physician.  We discuss a case of a patient with known advanced 
HIV infection presenting with headache to the emergency 
department. Given the range of possible diagnoses, broad-
spectrum antimicrobial therapy was initially commenced. This 
was stopped when magnetic resonance imaging conﬁ rmed a 
diagnosis of venous sinus thrombosis. Anticoagulation therapy 
was started in accordance with current clinical guidelines 
after discussing the rationale and options for treatment with 
the patient. Here, we review the guidelines and supporting 
evidence for management of venous sinus thrombosis, and 
consider the challenges and strategies for engaging a patient 
with previous poor attendance in their ongoing care. 
 KEYWORDS :  Anticoagulation ,  headache ,  HIV ,  tumour ,  venous 
sinus thrombosis 
 Case presentation 
 A 31-year-old man with known HIV presented with a 1-month 
history of global, constant headache. He reported a single 
episode of collapse with transient loss of consciousness that 
prompted presentation to the emergency department (ED). 
Past medical history included HIV with poor adherence 
to antiretroviral therapy (ARV) – latest blood CD4 count 
140 cells/µL (range 500–1500 cells/µL), plasma HIV 
load 200 copies/mL. He reported no history of previous 
opportunistic infections. He was allergic to penicillin and took 
mirtazapine for depression. Originally from the Democratic 
Republic of Congo, he had not left the UK for the previous 
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10 years. There was no history of recreational drug use. Systems 
review was unremarkable. 
 On examination, the patient was alert and his Glasgow Coma 
Scale was 15/15. Observations were within normal parameters 
and he was afebrile. On examination he had mild pain on 
neck flexion but no true neck stiffness. There was no rash, 
photophobia or other abnormal findings. Peripheral nervous 
system and cranial nerve examinations were normal. 
 Initial blood tests are summarised in Table  1 . Imaging 
comprised a chest radiograph and cranial computerised 
tomography (CT), which were both reported as normal. A 
lumbar puncture was performed, revealing a lymphocytic 
pleocytosis and an elevated opening pressure of 25 cm of water. 
Cerebrospinal fluid (CSF) samples were sent for microbiology 
(including rapid mycobacterial and fungal tests) and virology 
(Table  2 ). 
 Differential diagnosis 
 The differential diagnosis of prolonged headache in an HIV 
positive patient from a tropical region is broad; with a mild 
lymphocytic pleocytosis in the CSF, this includes tuberculosis 
(TB), viral meningoencephalitis, Listeria and cryptococcal 
meningitis. Space occupying lesions are another cause of 
headache in HIV. In developed countries, the most common 
causes are toxoplasmosis and primary CNS lymphoma. 1 
Infections, such as tuberculomas and aspergillomas, can also 
present as space-occupying lesions. In patients from developing 
countries, neurocystericosis should be considered in the 
differential. Other causes of a persistent headache range from 
 Table 1.  Blood results 
 Haematology Haemoglobin 119 g/L
White blood count 3.24×10 9 /L
Platelets 194×10 9 /L
 Biochemistry Sodium 137 mmol/L
Potassium 4.2 mmol/L
Urea 4.9 mmol/L
Creatinine 64 mmol/L
Liver function tests Within normal range
 Clotting INR 1.1 ratio
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imported infections like malaria, drug-induced headache, and, 
considering that HIV can be associated with a pro-coagulant 
state, 2 venous sinus thrombosis. 
 Initial management 
 In a severely immunocompromised patient presenting with 
persistent, prolonged headache with a lymphocytic CSF, 
empirical treatment for likely infectious causes was commenced 
pending further results. Intravenous aciclovir and high-
dose co-trimoxazole to cover Listeria were started in the ED 
(amoxicillin is first line for suspected Listeria meningitis, 
with co-trimoxazole used if, as here, there is a clear penicillin 
allergy). Given the sub-acute onset and history of emigration 
from a TB-endemic area, it was felt that empiric treatment for 
tuberculous meningitis using standard quadruple therapy was 
also indicated. 
 After 48 hours, the full results of the CSF sample were 
available (Table  2 ). CSF culture was negative, as was extended 
viral polymerase chain reaction (PCR); aciclovir and co-
trimoxazole were therefore stopped. Mycobacterial smear 
and TB PCR were negative, but as these tests are relatively 
insensitive in the context of TB meningitis (sensitivities 
reported as 45–80% 3 ), TB treatment was continued pending 
further imaging and results. 
 On the third day, MRI of the brain was performed to 
identify possible meningeal or parenchymal pathology. This 
demonstrated normal brain parenchyma and meninges. 
However, an increased superior sagittal sinus diameter, 
suspicious of a venous sinus thrombosis (Fig 1), was identified. 
A magnetic resonance venogram confirmed this diagnosis 
(Fig  2 ). 
 Case progression 
 Based on current Royal College of Physicians’ guidelines, 4 
anticoagulation therapy was started. The guidelines suggest 
warfarin; although in a patient with known variable 
adherence, decisions on anticoagulation must reflect 
their wishes and the need to optimise concordance. With 
previous poor attendance, at follow up, warfarin – with the 
requirement for regular monitoring – would be a high-risk 
strategy without proper safeguards in place. Although low 
molecular weight heparin injections would have alleviated 
the need for monitoring and could be administered in the 
community by a district nurse to ensure treatment was 
received, the patient declined long-term injections. A novel 
anticoagulant with oral administration and no need for 
regular monitoring would have been a simple solution but the 
potential interaction with ARVs precluded this. 
 Following discussion with the patient, inpatient warfarin 
loading, with the need for regular INR (International 
Normalised Ratio) monitoring clearly explained, was identified 
as a possible solution. The patient left hospital when the INR 
reached a therapeutic level. With text and telephone reminders, 
the patient attended for all scheduled appointments and 
completed the 6-month treatment course. 
 Table 2.  Cerebrospinal fluid results 
 Immediately 
available results 
Opening pressure 25 cm of water
Appearance Colourless and clear
White blood cell 
count
21/cu.mm (100% 
lymphocytes)
Glucose 3.4 mmol/L
Protein 0.43 g/L
 Microbiology Gram stain Organisms not seen
Culture No bacterial or fungal 
growth
India ink microscopy Negative
Mycobacteria smear 
and PCR
Negative
Cryptococcal antigen Negative
Syphilis serology Not performed as 
serology negative
 Virology HSV/VZV/Enterovirus/
Adenovirus/HHV6/
EBV/CMV
Negative
JC virus Negative
HIV1 RNA viral load 275,000 copies/mL
A B
 Fig 1.  Magnetic resonance image (MRI) of brain. A – axial T2w MRI at 
time of diagnosis demonstrates ‘round’ appearance of superior sagittal sinus 
(arrow), suggestive of distal occulusion by thrombus. B – this appearance has 
resolved on follow-up MRI after successful treatment with anticoagulation, 
with return to the normal ‘triangular’ shape. 
A B
 Fig 2.  Magnetic resonance venogram. A – nearly complete occlusion of 
the distal segment of the superior sagittal sinus with thrombus at time of 
diagnosis. B – following anticoagulation therapy, there is reconstitution of 
ﬂ ow within the sinus. 
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 Discussion 
 Headaches are a common presenting complaint in HIV positive 
patients, and may be initially encountered by general physicians 
on the acute medical take. The differential diagnosis of 
headache, particularly with travel to a tropical region, is broad 
and the clinician will need to consider everything from the 
common causes of chronic headache in the immunocompetent 
to opportunistic disease occurring in advanced HIV. The 
clinical presentation, the blood CD4 count, and travel history 
and previous place of residence are all relevant and should be 
taken into account. 
 Although there is no specific guidance regarding the 
assessment of headache in an HIV positive patient, the British 
HIV Association guidelines outline the investigation of fever 
of unknown origin with neurological symptoms. 4 Baseline 
investigations for any HIV patient presenting acutely should 
include a blood CD4 count (if not done within the last 3 
months), full blood count, kidney and liver function and 
C-reactive protein, bacterial and fungal blood cultures, chest 
X-ray and electrocardiogram. If neurological symptoms are 
present, cryptococcal antigen should be checked and a CT head 
and/or MRI head (depending on test availability and local 
practice) should be performed. CSF should be obtained for 
analysis. In our centre, we perform microscopy and culture, 
mycobacterial smear and TB PCR, India ink microscopy for 
fungus, cryptococcal antigen, syphilis serology and viral PCR. 
It is recommended that, if possible, a total of 10 mL of CSF 
is obtained, with at least 7 mL being sent for mycobacterial 
culture. Flow cytometry for intracranial haematological 
malignancies can also be performed. 
 Although infectious or malignant causes of headache must 
be excluded as a priority, it is important to consider non-
infectious causes of headache. A study of 200 patients with HIV 
found 53% reported headache symptoms, with 95% of these 
attributable to a primary headache syndrome (migraine or 
tension headache). 5 A detailed history, careful examination and 
thorough initial investigation, with a high index of suspicion for 
rare but serious causes are therefore essential for the assessment 
of a HIV positive patient presenting with headache. 
 A 2012 Cochrane review 6 of venous sinus thrombosis 
management concluded that anticoagulation was safe and 
could potentially reduce the risk of death or dependency. This 
is in line with the most recent American Stroke Association 
statement and current Royal College of Physicians guidelines, 7 
which suggest treatment with warfarin and low molecular 
weight heparin bridging unless contraindicated. 
 As with any treatment, it is vital that all possible steps are 
taken to optimise concordance. Without this engagement, the 
chance of long-term success is limited. As in the case presented, 
strategies to achieve this should be an integral part of the 
patient-centred, therapeutic approach. 
 Key learning points 
 > The differential diagnosis of headache in HIV is broad. 
Infective and non-infective causes should be considered, with 
previous residence, travel history and degree of immunosup-
pression taken into account. 
 > Where there is suspicion of intracranial infection, antimicro-
bial therapy should be promptly commenced with cover for 
viral, mycobacterial and fungal organisms as appropriate. 
 > HIV is a risk factor for thrombosis. In an HIV positive patient 
with long-standing headache, venous sinus thrombosis should 
be included in the differential. An MRI brain can offer a 
diagnostic clue. 
 > Current guidelines for the treatment of venous sinus 
thrombosis suggest anticoagulation with warfarin. Risks and 
benefi ts should be discussed with the patient and strategies to 
facilitate compliance put in place. ■
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